User contributions for Sujaya97

30 August 2022

• 09:4609:46, 30 August 2022 diff hist +59 Allergic conjunctivitis overview →Natural History, Complications and Prognosis
• 09:4509:45, 30 August 2022 diff hist −947 Allergic conjunctivitis overview →Epidemiology and Demographics
• 09:4409:44, 30 August 2022 diff hist −385 Allergic conjunctivitis overview →Overview
• 09:4209:42, 30 August 2022 diff hist +142 Allergic conjunctivitis future or investigational therapies →Overview current
• 09:4009:40, 30 August 2022 diff hist +923 Allergic conjunctivitis future or investigational therapies →Future developments
• 09:3409:34, 30 August 2022 diff hist +27 Allergic conjunctivitis future or investigational therapies →Future or Investigational therapies
• 09:3409:34, 30 August 2022 diff hist +1 Allergic conjunctivitis future or investigational therapies →Overview
• 09:3209:32, 30 August 2022 diff hist −21 Allergic conjunctivitis future or investigational therapies →Miscellaneous
• 09:2809:28, 30 August 2022 diff hist +20 Allergic conjunctivitis future or investigational therapies →Future or Investigational therapies
• 09:2509:25, 30 August 2022 diff hist +1,242 Allergic conjunctivitis future or investigational therapies →Omalizumab
• 09:1909:19, 30 August 2022 diff hist +694 Allergic conjunctivitis future or investigational therapies →Future or Investigational therapies
• 09:1909:19, 30 August 2022 diff hist +776 Allergic conjunctivitis future or investigational therapies /* Mapracorat{{cite journal| author=Baiula M, Spartà A, Bedini A, Carbonari G, Bucolo C, Ward KW | display-authors=etal| title=Eosinophil as a cellular target of the ocular anti-allergic action of mapracorat, a novel selective glucocorticoid receptor agonist. | journal=Mol Vis | year= 2011 | volume= 17 | issue= | pages= 3208-23 | pmid=22194647 | doi= | pmc=3244483 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2219...
• 09:1309:13, 30 August 2022 diff hist +537 Allergic conjunctivitis future or investigational therapies →Future or Investigational therapies
• 05:0605:06, 30 August 2022 diff hist +2,554 Allergic conjunctivitis future or investigational therapies →Future or Investigational therapies
• 04:5704:57, 30 August 2022 diff hist −65 Allergic conjunctivitis future or investigational therapies No edit summary
• 04:5304:53, 30 August 2022 diff hist +188 Allergic conjunctivitis cost-effectiveness of therapy →Overview current
• 04:4504:45, 30 August 2022 diff hist +141 Allergic conjunctivitis cost-effectiveness of therapy →Overview
• 04:4404:44, 30 August 2022 diff hist +154 Allergic conjunctivitis cost-effectiveness of therapy →Overview
• 04:4304:43, 30 August 2022 diff hist +1,330 Allergic conjunctivitis cost-effectiveness of therapy →Cost-effectiveness of therapy
• 04:3404:34, 30 August 2022 diff hist −71 Allergic conjunctivitis cost-effectiveness of therapy No edit summary
• 04:2604:26, 30 August 2022 diff hist +186 Allergic conjunctivitis secondary prevention →Overview current
• 04:2504:25, 30 August 2022 diff hist +1,805 Allergic conjunctivitis secondary prevention →Non-pharmacological measures
• 04:1904:19, 30 August 2022 diff hist +41 Allergic conjunctivitis secondary prevention →Treatment
• 04:1904:19, 30 August 2022 diff hist +213 Allergic conjunctivitis secondary prevention →Treatment
• 04:1404:14, 30 August 2022 diff hist +873 Allergic conjunctivitis secondary prevention →Secondary Prevention
• 04:1404:14, 30 August 2022 diff hist +65 Allergic conjunctivitis secondary prevention →Early diagnosis
• 04:1004:10, 30 August 2022 diff hist +1,905 Allergic conjunctivitis laboratory findings →Conjunctival allergen challenge
• 04:0704:07, 30 August 2022 diff hist +118 Allergic conjunctivitis laboratory findings →IgE estimation
• 04:0704:07, 30 August 2022 diff hist −300 Allergic conjunctivitis laboratory findings →Conjunctival allergen challenge
• 04:0304:03, 30 August 2022 diff hist +799 Allergic conjunctivitis laboratory findings →Laboratory findings
• 04:0104:01, 30 August 2022 diff hist +991 Allergic conjunctivitis laboratory findings →Skin prick test
• 03:5903:59, 30 August 2022 diff hist +667 Allergic conjunctivitis laboratory findings →IgE estimation
• 03:5503:55, 30 August 2022 diff hist +194 Allergic conjunctivitis laboratory findings →Skin prick test
• 03:5203:52, 30 August 2022 diff hist −5 Allergic conjunctivitis secondary prevention No edit summary
• 03:4803:48, 30 August 2022 diff hist +101 Allergic conjunctivitis primary prevention →Overview
• 03:4803:48, 30 August 2022 diff hist −3 Allergic conjunctivitis primary prevention →Primary Prevention
• 03:4803:48, 30 August 2022 diff hist +2,173 Allergic conjunctivitis primary prevention No edit summary

29 August 2022

• 19:0519:05, 29 August 2022 diff hist +81 Allergic conjunctivitis surgery No edit summary
• 19:0219:02, 29 August 2022 diff hist −683 Allergic conjunctivitis medical therapy →Overview
• 18:5718:57, 29 August 2022 diff hist −3 Allergic conjunctivitis medical therapy →Allergen specific immunotherapy
• 18:5718:57, 29 August 2022 diff hist +2,290 Allergic conjunctivitis medical therapy →Allergen specific immunotherapy
• 18:4818:48, 29 August 2022 diff hist +46 Allergic conjunctivitis medical therapy →Medical Therapy
• 18:4718:47, 29 August 2022 diff hist +2,311 Allergic conjunctivitis medical therapy →Topical antihistamines
• 18:3918:39, 29 August 2022 diff hist +37 Allergic conjunctivitis medical therapy →Medical Therapy
• 18:3918:39, 29 August 2022 diff hist +2,108 Allergic conjunctivitis medical therapy →Antihistamine–Vasoconstrictor Combinations
• 18:3218:32, 29 August 2022 diff hist +59 Allergic conjunctivitis medical therapy →Medical Therapy
• 18:3118:31, 29 August 2022 diff hist +454 Allergic conjunctivitis medical therapy →Leukkotriene receptor antagonists{{cite journal| author=Gane J, Buckley R| title=Leukotriene receptor antagonists in allergic eye disease: a systematic review and meta-analysis. | journal=J Allergy Clin Immunol Pract | year= 2013 | volume= 1 | issue= 1 | pages= 65-74 | pmid=24229824 | doi=10.1016/j.jaip.2012.07.001 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24229824 }}
• 18:2818:28, 29 August 2022 diff hist +512 Allergic conjunctivitis medical therapy →Medical Therapy
• 18:2618:26, 29 August 2022 diff hist +1,876 Allergic conjunctivitis medical therapy →Nonsteroidal Anti-inflammatory Drugs
• 18:2118:21, 29 August 2022 diff hist +55 Allergic conjunctivitis medical therapy →Medical Therapy